ImmunityBio, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC IBRX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

461,176

Value ($000)

913

Weight

0.0%

2021 Q1 - 2025 Q4 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	913	0.0%	461,176	12/31/2025
2025 Q3	11/14/2025	1,040	0.0%	422,831	9/30/2025
2025 Q2	8/14/2025	2,064	0.0%	781,800	6/30/2025
2025 Q1	5/19/2025	1,301	0.0%	432,341	3/31/2025
2024 Q4	2/14/2025	670	0.0%	261,734	12/31/2024
2024 Q3	11/14/2024	5,747	0.0%	1,544,802	9/30/2024
2024 Q2	8/14/2024	9,972	0.0%	1,577,827	6/30/2024
2024 Q1	5/15/2024	982	0.0%	182,930	3/31/2024
2023 Q4	2/14/2024	918	0.0%	182,930	12/31/2023
2023 Q3	11/13/2023	309	0.0%	182,930	9/30/2023
2023 Q2	8/11/2023	333	0.0%	182,930	6/30/2023
2023 Q1	5/15/2023	333	0.0%	182,930	3/31/2023
2022 Q4	2/14/2023	746	0.0%	147,198	12/31/2022
2022 Q3	11/14/2022	673	0.0%	135,355	9/30/2022
2022 Q2	8/12/2022	573	0.0%	154,037	6/30/2022
2022 Q1	5/16/2022	566	0.0%	100,861	3/31/2022
2021 Q4	2/14/2022	613	0.0%	100,861	12/31/2021
2021 Q3	11/15/2021	420	0.0%	43,139	9/30/2021
2021 Q2	8/16/2021	370	0.0%	25,922	6/30/2021
2021 Q1	5/14/2021	515	0.0%	21,700	3/31/2021